ABT-046 is a potent and selective oral DGAT-1 inhibitor used in metabolic disease research. It has been employed in studies investigating obesity and type 2 diabetes, demonstrating utility in both in vitro enzymatic assays and in vivo models of metabolic dysfunction.
Molecular Weight:
350.41
Purity:
98.13% (May vary between batches)
CAS Number:
[1031336-60-3]
Formula:
C20H22N4O2
Target:
Transferase,Acyltransferase
Application Notes:
Solubility: DMSO:50 mg/mL (142.69 mM)
* VAT and and shipping costs not included. Errors and price changes excepted
